Depression and quality of life in OCD; ACT vs SSRIs. N=27. Ebrahimi, A., Nasre Esfahan, E., Akuchekian, S., Izadi, R., Shaneh, E., & Mahaki, B. (2022). A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obse
Overview
This indexed entry references a 2022 randomized clinical trial by Ebrahimi et al. comparing group acceptance and commitment therapy with pharmacological treatment for depression and quality of life in patients with obsessive-compulsive disorder. The study included 27 participants and was published in the Journal of Research in Medical Sciences. The provided text contains only bibliographic details without an abstract or summary of findings.
- ID
3ceeebfbbf6f4448- Source org
- ACBS
- Author
- Not recorded
- Published
- Not recorded
- OA status
- Not recorded
- DOI
- Not recorded
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- Not recorded
Tags
Verification
- legitimacykeep via unknown · score 0.95 · checked_at unknown
- linkok via http-check · 2026-07-21T15:41:41.820142+00:00
Cite this entry
BibTeX
@article{allodium:3ceeebfbbf6f4448,
title = {Depression and quality of life in OCD; ACT vs SSRIs. N=27. Ebrahimi, A., Nasre Esfahan, E., Akuchekian, S., Izadi, R., Shaneh, E., \& Mahaki, B. (2022). A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obse},
journal = {ACBS},
url = {https://contextualscience.org/act_randomized_controlled_trials_1986_to_present}
}RIS
TY - JOUR TI - Depression and quality of life in OCD; ACT vs SSRIs. N=27. Ebrahimi, A., Nasre Esfahan, E., Akuchekian, S., Izadi, R., Shaneh, E., & Mahaki, B. (2022). A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obse PB - ACBS UR - https://contextualscience.org/act_randomized_controlled_trials_1986_to_present ER -
APA
Depression and quality of life in OCD; ACT vs SSRIs. N=27. Ebrahimi, A., Nasre Esfahan, E., Akuchekian, S., Izadi, R., Shaneh, E., & Mahaki, B. (2022). A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obse. (n.d.). ACBS. https://contextualscience.org/act_randomized_controlled_trials_1986_to_present
Related entries
- OCD symptoms. ACT+SSRIs, vs. Exposure and response prevention +SSRI, vs. continued SSRIs. N=40. Zemestani M, Salavati M, Seyedolshohadayi A, et al. (2022). A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Di
- An Iranian study of group acceptance and commitment therapy versus group cognitive behavioral therapy for adolescents with obsessive-compulsive disorder on an optimal dose of selective serotonin reuptake inhibitors
- OCD, Quality of life. ACT vs. CBT/ERP. N=176. Nielsen, S. K. K., Stuart, A. C., Winding, C., Øllgaard, M., Wolitzky-Taylor, K., Daniel, S. I. F., Vangkilde, S., Rosenberg, N., Hageman, I., & Jørgensen, M. B. (2025). Group acceptance and commitment therapy versus cognitive behavioral therapy/exposure
- Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder
- OCD symptoms. Group ACT vs. wait list. N=72. Lee, S. W., Choi, M., & Lee, S. J. (2023). A randomized controlled trial of group-based acceptance and commitment therapy for obsessive-compulsive disorder. Journal of Contextual Behavioral Science, 27, 45-53. DOI: 10.1016/j.jcbs.2022.11.009
- OCD symptoms. TAU w/ medications vs TAU w/ medications + ACT. N=62. Akhouri, D., Hamza, S., Kumar, S., & Reyazuddin, M. (2023). Acceptance and commitment therapy as an add-on treatment for the management of patients with obsessive-compulsive disorder. Industrial Psychiatry Journal, 32 (Suppl 1), S17
- OCD. ACT vs control group. N=44 Lee, S., Choi, M., & Lee, S. (2022). Effectiveness of a Group-Based Acceptance and Commitment Therapy for Obsessive-Compulsive Disorder in a University Hospital. Journal of the Korean Society of Biological Therapies in Psychiatry, 28 (1), 49-56. Retrieved from: https:
- OCD symptoms; Religiously modified ACT vs. conventional ACT; N=36. Dehaghi, A. A., Dolatshahi, B., Taremian, F., Pourshahbaz, A., & Ansar, H. (2024) Evaluation of an acceptance and commitment therapy with religious content to control obsessive-compulsive disorder, dysfunctional beliefs, feeling guil
- OCD symptoms; Sertraline + ACT) vs transcranial magnetic stimulation. N=63. Zou, J. Z., Wu, S. L., Yuan, X., Hu, Z. Z., Tang, J., & Hu, M.R. (2022). Effects of Acceptance and Commitment Therapy and Repetitive Transcranial Magnetic Stimulation on Obsessive-Compulsive Disorder. Frontiers in Psychiatry
- OCD symptoms. ACT vs CBT, vs MCT, vs MiCBT. N=80. Derakhtkar, A., Khezrimoghadam, N., & Fazilatpour, M. (2022). The Effectiveness of Mindfulness-Integrated Cognitive Behavioral Therapy (MiCBT), Meta-Cognitive Therapy (MCT), Acceptance and Commitment Therapy (ACT), and Cognitive Behavioral Therapy (C